[Value of prevention of congenital toxoplasmosis].

  • 1 January 1996
    • journal article
    • abstracts
    • Vol. 19  (5) , 330-4
Abstract
To verify incidence of toxoplasmosis seroconversion during pregnancy and the interest of treating the mother. Among 7044 infants born between January 1989 and December 1993, 78 (1.1%) born to mothers who developped toxoplasmosis seroconversion during pregnancy were followed. Among 69 mothers treated, there were only 9 cases of congenital toxoplasmosis (13.4%) including only 3 cases of patent toxoplasmosis. Treating the mother is an effective means of preventing toxoplasmosis. The cost of verifying seronegativity in women during pregnancy could be reduced by primary prevention.

This publication has 0 references indexed in Scilit: